Official data hindered by government shutdown; alternative price indicators show easing inflationary pressures
Jinse Finance reported that, according to price data from the U.S. price statistics organization OpenBrand, inflation for U.S. consumer durables and personal goods slowed in October for the first time in three months. The organization's index measuring prices of large items and personal care products rose by 0.22% last month, down from a 0.48% increase in September. OpenBrand tracks prices daily from online marketplaces, retail websites, and physical store listings, and stated that price growth slowed across all categories except for communication devices. Michael Metcalfe, head of macro strategy at State Street Bank, said, "As we enter the seasonal discount period, this still needs to be monitored closely, but for now, inflation remains resilient but not alarming." These results indicate that as inflation-weary consumers become more cost-conscious, merchants are limiting price increases to maintain market share. The data also suggests that tariffs have had an uneven impact on consumer prices in recent months, rather than causing sustained cumulative price pressure. With the release of official reports delayed due to the federal government's record shutdown, alternative economic data is receiving increased attention.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
House of Doge (HODO.US) executives resign and terminate exclusive Dogecoin authorization
The former CEO and CFO of House of Doge have resigned, with executives from McQueen Labs taking over. The company has terminated its exclusive trademark authorization for Dogecoin, switching to a non-exclusive model that requires revenue sharing. Meanwhile, asset swaps and acquisitions are being advanced.
Vietnam VN Index closed down 0.6%

Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.
Windward Bio Group filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to 100 million dollars.

A Contrarian Amid the Selloff in French Bonds: 370 billion AUD Pension Fund Increases Holdings, Betting That Fiscal Risks Are Overestimated
Australia's second largest pension fund is buying French government bonds. The institution believes that the market has overreacted in pricing France's fiscal predicament and the European Central Bank's interest rate hike outlook.
